A prospective study stratifying patients to follow up intervals based on risk of recurrence post wide field colonic EMR.
- Conditions
- Large colorectal polyps10017934
- Registration Number
- NL-OMON44414
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 250
Patients referred for endoscopic removal of a large sessile colonic polyp sized bigger or are 20mm
Age >18 years
Able to give informed consent to involvement in trial
-Lesion involving the ileocaecal valve
-Pregnancy: currently pregnant or attempting to become pregnant
-Lactation: currently breastfeeding
-Taken clopidogrel within 7 days
-Taken warfarin within 5 days
-Had full therapeutic dose unfractionated heparin within 6 hours
-Had full therapeutic dose low molecular weight heparin (LMWH) within 12 hours
-Known clotting disorder
-Previous attempt at EMR of the polyp referred for resection
-Known with or the endoscopic suspicion of the presence of hereditary polyposis, such as FAP, Lynch syndrome and serrated polyposis syndrome or bowel cancer syndrome
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure is the presence of residual/recurrence of polyp<br /><br>tissue at or immediately surrounding the previous EMR site at follow up<br /><br>colonoscopic procedures (at 18 months and 36 months) after WF-EMR involving the<br /><br>SCAR technique of either SERT 0 lesions or SERT 1-4 lesions. </p><br>
- Secondary Outcome Measures
Name Time Method